Conditioned taste aversion produced by cyclosporine A: Concomitant reduction in lymphoid organ weight and splenocyte proliferation

Physiology and Behavior

Volumn 63, Issue 2, 1998, Pages 241-247

  Exton, Michael S ^a   Hörsten, Stephan Von ^a   Vöge, Jochen ^b   Westermann, Jürgen ^a   Schult, Marc ^a   Nagel, Eckard ^a   Schedlowski, Manfred ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Conditioned taste aversion; Cyclosporine A; Organ weight; Proliferation; Rat; Spleen; Thymus

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; IMMUNE SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SPLEEN; TASTE AVERSION; THYMUS;

EID: 0031963323     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00432-0     Document Type: Article

References (38)

1. Ader R., Cohen N. Behaviorally conditioned immunosuppression. Psychosom. Med. 37:1975;333-340.
2. Ader R., Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science. 215:1982;1534-1536.
3. Ader R., Cohen N. CNS-immune system interactions Conditioning phenomena . Behav. Brain Sci. 8:1985;379-395.
4. Ader R., Cohen N. Truly, conditioned responses are conditioned. Behav. Brain. Sci. 9:1986;760-763.
5. Ader R., Cohen N. Psychoneuroimmunology Conditioning and stress . Annu. Rev. Psychol. 44:1993;53-85.
6. Benschop R. J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis Early observations, current research, and future directions . Brain Behav. Immun. 10:1996;77-91.
7. Beschorner W. E., Namnoun J. D., Hess A. D., Shinn C. A., Santos G. W. Cyclosporin A and the thymus. Immunopathology. Am. J. Pathol. 126:1987;487-496.
8. Besedovsky H., del Rey A. Immune-neuro-endocrine interactions Facts and hypotheses . Endocrine. Rev. 17:1996;1-39.
9. Bovbjerg D., Cohen N., Ader R. Behaviorally conditioned enhancement of delayed-type hypersensitivity in the mouse. Brain Behav. Immun. 1:1987;64-71.
10. Calne R. Impact of immunosuppressants on host tissues and tolerance. Transplant. Proc. 26:1994;3065-3070.
11. Cosenza C. A., Cramer D. V., Eiras-Hreha G., Cajulis E., Wang H. K., Makowka L. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat. Transplantation. 56:1993;667-672.
12. Croiset G., Heijnen C. J., van der Wal W. E., de Boer S. F., de Wied D. A role for the autonomic nervous system in modulating the immune response during mild emotional stimuli. Life Sci. 46:1990;419-425.
13. Daar A. S., Pingle S., Naiem M., Masri M. A. Histologic changes in atrophic spleens of mice treated with cyclosporine A. Transplant. Proc. 19:1987;4329-4330.
14. Dos G. A., Shevach E. M. Effect of cyclosporin A on T cell function in vitro The mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell . J. Immunol. 129:1982;2360-2367.
15. Exton M. S., Lightfoot J. B., Stanton M. W., Bull D. F., King M. G., Husband A. J. Behaviorally conditioned anorexia Role of gastric emptying and prostaglandins . Physiol. Behav. 58:1996;471-476.
16. Fox R. A., McKenna S. Conditioned taste aversion induced by motion is prevented by selective vagotomy in the rat. Behav. Neural Biol. 50:1988;275-284.
17. Goldin H., Keisari Y. The effect of cyclosporine on macrophage oxidative burst potential during graft-versus-host reactions in mice. Transplantation. 47:1989;548-552.
18. Grochowicz P. M., Schedlowski M., Husband A. J., King M. G., Hibberd A. D., Bowen K. M. Behavioral conditioning prolongs heart allograft survival in rats. Brain Behav. Immun. 5:1991;349-356.
19. Hiramine C., Hojo K., Matsumoto H., Koseto M., Itoh M. Differential effect of cyclosporine in vivo on the distribution of T cell subsets in the thymus, spleen, and lymph nodes. Transplantation. 47:1989;499-503.
20. Hiramoto R. N., Hsueh C-M., Rogers C. F., Demissie S., Hiramoto N. S., Soong S.-J., Ghanta V. K. Conditioning of the allogeneic cytotoxic lymphocyte response. Pharmacol. Biochem. Behav. 44:1993;275-280.
21. Kahan B. D. Cyclosporine. N. Eng. J. Med. 321:1989;1725-1738.
22. Kelley K. W., Dantzer R., Mormede P., Salmon H., Aynaud J. M. Conditioned taste aversion suppresses induction of delayed-type hypersensitivity immune reactions. Physiol. Behav. 34:1985;189-193.
23. King M. G., Husband A. J., Kusnecov A. W. Behaviourally conditioned immunosuppression using anti-lymphocyte serum Duration of effect and role of corticosteroids . Med. Sci. Res. Biochem. 15:1987;407-408.
24. Kiziliski T. A., Sigalet D. L., Shnitka T. K., Kneteman N. M. The impact of surgical technique on the development of graft versus host disease in a rat small intestine transplant model. Transplantation. 60:1995;276-281.
25. Klosterhalfen S., Klosterhalfen W. Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. Behav. Neurosci. 104:1990;716-724.
26. Kusnecov A. W., Husband A. J., King M. G. The influence of dexamethazone on behaviorally conditioned immunomodulation and plasma corticosterone. Brain Behav. Immun. 4:1990;50-66.
27. Kusnecov A. W., Sivyer M., King M. G., Husband A. J., Cripps A. W., Clancy R. L. Behaviorally conditioned suppression of the immune response by antilymphocyte serum. J. Immunol. 130:1983;2117-2120.
28. Luecken L. J., Lysle D. T. Evidence for the involvement of β-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 38:1992;209-220.
29. Luke D. R., Brunner L. J., Vadiei K. Bioavailability assessment of cyclosporine in the rat Influence of route of administration . Drug Metabol. Dispos. 18:1990;158-162.
30. Lysle D. T., Cunnick J. E., Maslonek K. A. Pharmacological manipulation of immune alterations induced by an aversive conditioned stimulus Evidence for a β-adrenergic receptor-mediated pavlovian conditioning process . Behav. Neurosci. 105:1991;443-449.
31. Madden K. S., Felten D. L. Experimental basis for neural-immune interactions. Physiol. Rev. 75:1995;77-106.
32. Morato E. F., Gerbase-DeLima M., Gorczynski R. M. Conditioned immunosuppression in orally immunized mice. Brain Behav. Immun. 10:1996;44-54.
33. Ryffel B., Deysseroth H., Borel J. F. Cyclosporin A Effects on the mouse thymus . Agents Actions. 11:1981;373-379.
34. 2-adrenergic mechanisms. J. Immunol. 156:1996;93-99.
35. Schedlowski, M.; Tewes, U. (Eds.) Psychoneuroimmunologie. Heidelberg: Spektrum; 1996.
36. Schumacher A., Nordheim A. Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression. Clin. Invest. 70:1992;773-779.
37. Solvason H. B., Ghanta V. K., Soong S.-J., Rogers C. F., Hsueh C-M., Hiramoto N. S., Hiramoto R. N. A simple, single, trial-learning paradigm for conditioned increase in natural killer cell activity. Proc. Soc. Exp. Biol. Med. 199:1992;199-203.
38. Westermann J., Nagahori Y., Walter S., Heerwagen C., Miyasaka M., Pabst R. B., Pabst R. B and T lymphocyte subsets enter peripheral lymph nodes and Peyer's patches without preference in vivo No correlation occurs between their localization in different types of high endothelial venules and the expression of CD44, VLA-4, LFA-1, ICAM-1, CD2 or L-selectin . Eur. J. Immunol. 24:1994;2312-2316.